Literature DB >> 3614257

Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers.

G Rouleau, G Karpati, S Carpenter, M Soza, S Prescott, P Holland.   

Abstract

The combined effects of dexamethasone treatment (1 mg/Kg/day) plus denervation (DEX-DEN), were studied at 7, 13, and 28 days by microscopic, biochemical, and physiological techniques in plantaris and soleus muscles of adult rats. The results were compared with corresponding dexamethasone-treated (DEX) and denervated (DEN) muscles and appropriate controls. There was a significantly more marked atrophy of all fiber types in the DEX-DEN plantares at 7 and 13 days than in either DEX or DEN muscles. The degree of atrophy was greatest in type 2B fibers in DEX-DEN plantares. Electron microscopy revealed a severe preferential depletion of thick myofilaments in DEX-DEN plantares and solei but not in DEX or DEN muscles. The thick myofilament depletion in DEX-DEN muscles occurred in addition to a severe overall reduction of myofibrillar caliber. Gel electrophoresis showed a marked preferential decrease of myosin heavy chain in DEX-DEN plantares and solei, but not in either DEX or DEN muscles. Myosin light chains were also markedly reduced in DEX-DEN plantares and solei. In vitro physiological studies showed a marked reduction of the denervation-induced twitch potentiation in DEX-DEN solei. Maximal tetanic tension (20 Hz stimulation) per gram weight of muscle as well as the twitch-tetanus ratio was significantly reduced only in DEX-DEN solei in relation to controls. Myosin depletion in DEX-DEN muscles may be due to a severe preferential inhibition of its synthesis coupled with an accelerated catabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3614257     DOI: 10.1002/mus.880100509

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

Review 1.  [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].

Authors:  K Judemann; D Lunz; Y A Zausig; B M Graf; W Zink
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

Review 2.  Dysregulation of sodium channel gating in critical illness myopathy.

Authors:  James W Teener; Mark M Rich
Journal:  J Muscle Res Cell Motil       Date:  2006-07-28       Impact factor: 2.698

3.  Distinct muscle apoptotic pathways are activated in muscles with different fiber types in a rat model of critical illness myopathy.

Authors:  Benjamin T Barnes; Amy L Confides; Mark M Rich; Esther E Dupont-Versteegden
Journal:  J Muscle Res Cell Motil       Date:  2015-03-05       Impact factor: 2.698

Review 4.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

5.  Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy.

Authors:  Susan D Kraner; Qingbo Wang; Kevin R Novak; Dongmei Cheng; David R Cool; Junmin Peng; Mark M Rich
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-06       Impact factor: 3.619

6.  Impact of post-synaptic block of neuromuscular transmission, muscle unloading and mechanical ventilation on skeletal muscle protein and mRNA expression.

Authors:  H Norman; J Nordquist; P Andersson; T Ansved; X Tang; B Dworkin; L Larsson
Journal:  Pflugers Arch       Date:  2006-07-26       Impact factor: 3.657

7.  Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers.

Authors:  Alastair Khodabukus; Amulya Kaza; Jason Wang; Neel Prabhu; Richard Goldstein; Vishal S Vaidya; Nenad Bursac
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

Review 8.  Critical illness myopathy and polyneuropathy.

Authors:  Shawn J Bird; Mark M Rich
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

Review 9.  Mechanisms of neuromuscular dysfunction in critical illness.

Authors:  Jaffar Khan; Taylor B Harrison; Mark M Rich
Journal:  Crit Care Clin       Date:  2008-01       Impact factor: 3.598

Review 10.  Critical illness myopathy.

Authors:  David Lacomis
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.